What is PharmAssist?
Founded in 1989, PharmAssist operates as a specialized analytical laboratory dedicated to providing comprehensive testing services for the pharmaceutical industry. The company distinguishes itself through a rigorous focus on cGMP compliance and a proactive approach to integrating the latest advancements in analytical test method technology. By maintaining deep expertise in drug product regulatory requirements, PharmAssist serves as a critical partner for organizations navigating the complexities of drug development and quality control. Its market position is defined by a reputation for delivering cost-effective, timely, and scientifically precise data, which is essential for ensuring product safety and regulatory approval.
How much funding has PharmAssist raised?
PharmAssist has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in PharmAssist
PPP
Public-Private Partnership
What's next for PharmAssist?
With the recent influx of capital, PharmAssist is poised to accelerate its growth strategy, focusing on the expansion of its analytical service portfolio and the modernization of its laboratory facilities. The company is expected to prioritize investments in advanced instrumentation and talent acquisition to address the increasing complexity of drug product testing. As regulatory scrutiny intensifies globally, PharmAssist's commitment to staying abreast of technological developments will likely serve as a primary driver for its future market expansion. The firm is well-positioned to capitalize on the growing demand for outsourced analytical services, ensuring that its clients remain compliant while optimizing their own development timelines.
See full PharmAssist company page
